spacer gif spacer gif spacer gif spacer gif spacer gif
QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

This Article
Right arrow Summary Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ohara, R.
Right arrow Articles by Toyoshima, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ohara, R.
Right arrow Articles by Toyoshima, K.
Aoki, M., Akiyama, T., Miyoishi, J. and Toyoshima, K (1991). Identification and characterization of protein products of the cot oncogene with serine kinase activity. Oncogene 6, 1515-1519.[Medline]

Aoki, M., Hamada, F., Sugimoto, T., Sumida, S., Akiyama, T. and Toyoshima, K (1993). The human cot proto-oncogene encodes two protein serine/threonine kinases with different transforming activities by alternative initiation of translation. J. Biol. Chem 30, 22723-22732.

Biggs, W. H., III, and Zipursky, S. L (1991). Primary structure, expression, and signal-dependent tyrosine phosphorylation of a Drosophila homolog of extracellular signal-regulated kinase. Proc. Nat. Acad. Sci. USA 89, 6296-6299.

Bellacosa, A., Testa, J. R., Staal, S. P. and Tsichlis, P. N (1991). A retroviral oncogene, akt , encoding a serine-threonine kinase containing an SH2-like region. Science 254, 274-277.[Abstract/Free Full Text]

Blenis, J (1993). Signal transduction via the MAP kinases: proceed at your own RSK. Proc. Nat. Acad. Sci. USA 90, 5889-5892.[Abstract/Free Full Text]

Bonner, T. I., Kerby, S. B., Sutrave, P., Gunnell, M. A., Mark, G. and Rapp, U. R (1985). Structure and biological activity of human homolog of the raf/mil oncogene. Mol. Cell. Biol 5, 1400-1407.[Abstract/Free Full Text]

Bonner, T. I., Oppermann, H., Seeburg, P., Kerby, S. B., Gunnell, M. A., Young, A. C. and Rapp, U. R (1986). The complete coding sequence of the human raf oncogene and the corresponding structure of the c- raf -1 gene. Nucl. Acids Res 12, 1009-1015.

Cantley, L. C., Auger, K. R., Carpenter, C., Duckworth, B., Graziani, A., Kapeller, R. and Soltoff, S (1991). Oncogenes and signal transduction. Cell 64, 281-302.[Medline]

Chan, A. M.-L., Chedid, M., Mcgovern, E. S., Popescu, N. C., Miki, T. and Aaronson, S. A (1993). Expression cDNA cloning of a serine kinase transforming gene. Oncogene 8, 1329-1333.[Medline]

Chomczynski, P. and Sacchi, N (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem 162, 156-159.[Medline]

Courchense, W. E., Kunisawa, R. and Thorner, J (1989). A putative protein kinase overcomes pheromone-induced arrest of cell cycling in S. cerevisiae. Cell 58, 1107-1119.[Medline]

Dent, P., Haser, W., Haystead, T. A. J., Vincent, L. A., Roberts, T. M. and Sturgill, T. W (1992). Activation of mitogen-activated protein kinase kinase by v-Raf in NIH 3T3 cells and in vitro. Science 257, 1404-1407.[Abstract/Free Full Text]

Downward, J., Yarden, Y., Mayes, E., Scrace, G., Totty, N., Stockwell, P., Ullrich, A., Schlessinger, J. and Waterfield, M. D (1984). Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences. Nature 307, 521-527.[Medline]

Elion, E. A., Grisafi, P. L. and Fink, G. R (1990). FUS3 encodes acdc2+/CDC28-related kinase required for the transition from mitosis into conjugation. Cell 60, 649-664.[Medline]

Hanks, S. K. and Quinn, A. M (1991). Protein kinase catalytic domain sequence database: identification of conserved features of primary structure and classification of family members. Meth. Enzymol 200, 38-62.[Medline]

Howe, L. R., Leevers, S. J., Go'mez, N., Nakienly, S., Cohen, P. and Marshall, C. J (1992). Activation of the MAP kinase pathway by the protein kinase raf. Cell 71, 335-342.[Medline]

Jones, P. F., Jakubowica, T., Pitossi, F. J., Maurer, F. and Hemmings, B. A (1991). Molecular cloning and identification of a serine/threonine protein kinase of the second-messenger subfamily. Proc. Nat. Acad. Sci.USA 88, 4171-4175.[Abstract/Free Full Text]

Jove, R. and Hanafusa, H (1987). Cell transformation by the viral src oncogene. Annu. Rev. Cell Biol 3, 31-56.

Kariakis, J. M., App, H., Zhang, X., Banerjee, P., Brautugan, D. L., Rapp, U. R. and Avruch, J (1992). Raf-1 activates MAP kinase-kinase. Nature 358, 417-421.[Medline]

Kosako, H., Gotoh, Y., Matsuda, S., Ishikawa, M. and Nishida, E (1992). Xenopus MAP kinase activator is a serine/threonine kinase activated by threonine phosphorylation. EMBO J 11, 2903-2908.[Medline]

Kosako, H., Nishida, E. and Gotoh, Y (1993). cDNA cloning of MAP kinase kinase reveals kinase cascade pathways in yeasts to vertebrates. EMBO J 12, 787-794.[Medline]

Lange-Carter, C. A., Pleiman, C. M., Gardner, A. M., Blumer, K. J. and Johnson, G. L (1993). A divergence in the MAP kinase regulatory network defined by MEK kinase and Raf. Science 260, 315-319.[Abstract/Free Full Text]

Lewin, B (1991). Oncogenic conversion by regulatory changes in transcription factors. Cell 64, 303-312.[Medline]

Matsuda, S., Kosako, H., Takenaka, K., Moriyama, K., Sakai, H., Akiyama, T., Gotoh, Y. and Nishida, E (1992). Xenopus MAP kinase activator: identification and function as a key intermediate in the phosphorylation. EMBO J 11, 973-982.[Medline]

Miyoshi, J., Higashi, T., Mukai, H., Ohuchi, T. and Kakunaga, T (1991). Structure and transforming potential of the human cot oncogene encoding a putative protein kinase. Mol. Cell. Biol 11, 4088-4096.[Abstract/Free Full Text]

Nadin-Davis, S. A. and Nasim, A (1988). A gene which encodes a predicted protein kinase can restore some functions of the ras gene in fission yeast. EMBO J 7, 985-993.[Medline]

Nomura, S., Willis, A. J., Edwards, D. R., Heath, J. K. and Hogan, B. L. M (1988). Developmental expression of 2ar (osteopontin) and SPARAC (osteonectin) RNA as revealed by in situ hybridization. J. Cell Biol 106, 441-450.[Abstract/Free Full Text]

Ohara, R., Miyoshi, J., Aoki, M. and Toyoshima, K (1993). The murine cot proto-oncogene : genome structure and tissue-specific expression. Jpn J. Cancer Res 84, 518-525.[Medline]

Padma, R. and Nagarajan, L (1991). The human PIM -1 gene product is a protein serine kinase. Cancer Res 51, 2486-2489.[Abstract/Free Full Text]

Pelech, S. L. and Sanghera, J. S (1992). MAP kinases : charting the regulatory pathways. Science 257, 1355-1356.[Free Full Text]

Reddy, E. P., Reynolds, R. K., Santos, E. amd Barbacid, M (1982). A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene. Nature 300, 149-152.[Medline]

Rhodes, N., Connell, L., and Errede, B (1990). STE11 is a protein kinase required for cell-type-specific transcription and signal transduction in yeast. Genes Dev 4, 1862-1874.[Abstract/Free Full Text]

Sagata, N., Oskarsson, M., Copeland, T., Brumbaugh, J. and Van de Woude, G. F (1988). Function of c- mos proto-oncogene product in meiotic maturation in Xenopus oocytes. Nature 335, 519-525.[Medline]

Sagata, N., Watanabe, N., Van de Woude, G. F., and Ikawa, Y (1989). The c- mos proto-oncogene product is a cytostatic factor responsible for meiotic arrest in vertebrate eggs. Nature 342, 512-518.[Medline]

Schmidt, M., Oskarsson, M., Dunn, J. K., Blair, D. G., Hughes, S., Propst, F. and Van de Woude, G. F (1988). Chicken homolog of the mos proto-oncogene. Mol. Cell. Biol 8, 923-929.[Abstract/Free Full Text]

Seger, R., Ahn, N. G., Posad, J., Munar, E. S., Jensen, A. M., Cooper, J. A., Cobb, M. H. and Krebs, E. G (1992). Purification and characterization of mitogen-activated protein kinase activator(s) from epidermal growth factor-stimulated A 431 cells. J. Biol. Chem 267, 14373-14381.[Abstract/Free Full Text]

Selton, G., Cuypers, H. T., Boelens, W., Robanus-Maandag, E., Verbeek, J., Domen, J., van Bevere, C. and Berns, A (1986). The primary structure of the putative oncogene pim -1 shows extensive homology with protein kinases. Cell 46, 603-611.[Medline]

Teague, M. A., Chaleff, D. T. and Errede, B (1986). Nucleotide sequence of the yeast regulatory gene STE7 predicts a protein homologous to protein kinases. Proc. Nat. Acad. Sci. USA 83, 7371-7375.[Abstract/Free Full Text]

Toda, T., Shimanuki, M. and Yanagida, M (1991). Fission yeast genes that confer resistance to staurosporine encode an AP-1-like transcription factor and a protein kinase related to the mammalian ERK/MAP 2 and budding yeast FUS3 and KSS1 kinases. Genes Dev 5, 60-73.[Abstract/Free Full Text]

Tsuda, L., Inoue, Y. H., Yoo, M., Mizuno, M., Hata, M., Lim, Y., Adachi-Yamada, T., Ryo, H., Masamune, Y. and Nishida, Y (1993). A protein kinase similar to MAP kinase activator acts downstream of the Raf kinase in Drosophila. Cell 72, 407-414.[Medline]

Wang, Y., Xu, H.-P., Riggs, M., Rodgers, L. A. and Wigler, M (1991). byr2 , a Schizosaccahromyces pombe gene encoding a protein kinase capable of partial suppression of the ras 1 mutant phenotype. Mol. Cell. Biol 11, 3554-3564.[Abstract/Free Full Text]

Watson, R., Oskarson, M. and Van de Woude, G. F (1982). Human DNA sequence homologous to the transforming gene ( mos) of Moloney murine sarcoma virus. Proc. Nat. Acad. Sci. USA 79, 4078-4082.[Abstract/Free Full Text]

Wu, J., Harrison, J. K., Vincent, L. A., Haystead, C., Haystead, T., A., J., Michel, H., Hunt, D. F., Lynch, K. R. and Sturgill, T. W (1993). Molecular structure of a protein-tyrosine/threonine kinase activation p42 mitogen-activated protein (MAP) kinase: MAP kinase kinase. Proc. Nat. Acad. Sci. USA 90, 173-177.[Abstract/Free Full Text]


This article has been cited by other articles:


Home page
 Molecular Cancer TherapeuticsHome page
A. Munshi, J. F. Kurland, T. Nishikawa, P. J. Chiao, M. Andreeff, and R. E. Meyn
Inhibition of constitutively activated nuclear factor-{kappa}B radiosensitizes human melanoma cells
Mol. Cancer Ther., August 1, 2004; 3(8): 985 - 992.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. F. Kurland, D. W. Voehringer, and R. E. Meyn
The MEK/ERK Pathway Acts Upstream of NF{kappa}B1 (p50) Homodimer Activity and Bcl-2 Expression in a Murine B-Cell Lymphoma Cell Line: MEK INHIBITION RESTORES RADIATION-INDUCED APOPTOSIS
J. Biol. Chem., August 22, 2003; 278(34): 32465 - 32470.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
A. G. Eliopoulos, C. Davies, S. S. M. Blake, P. Murray, S. Najafipour, P. N. Tsichlis, and L. S. Young
The Oncogenic Protein Kinase Tpl-2/Cot Contributes to Epstein-Barr Virus-Encoded Latent Infection Membrane Protein 1-Induced NF-{kappa}B Signaling Downstream of TRAF2
J. Virol., March 27, 2002; 76(9): 4567 - 4579.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Summary Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ohara, R.
Right arrow Articles by Toyoshima, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ohara, R.
Right arrow Articles by Toyoshima, K.